118 related articles for article (PubMed ID: 8099541)
21. Neutropenia in patients with inflammatory arthritis treated with sulphasalazine.
Farr M; Symmons DP; Blake DR; Bacon PA
Ann Rheum Dis; 1986 Sep; 45(9):761-4. PubMed ID: 2876683
[TBL] [Abstract][Full Text] [Related]
22. Treatment of the seronegative spondyloarthropathies with sulfasalazine.
Zwillich SH; Comer SS; Lee E; Erdman WA; Lipsky PE
J Rheumatol Suppl; 1988 Sep; 16():33-9. PubMed ID: 2903925
[TBL] [Abstract][Full Text] [Related]
23. Abrupt occurrence of high fever and rash in a patient treated with sulphasalazine for psoriatic arthritis.
Fischetti F; Gerloni R; Bardelli M; Carretta R
Minerva Med; 2003 Dec; 94(6):437-44. PubMed ID: 14976471
[TBL] [Abstract][Full Text] [Related]
24. Sulphasalazine and ankylosing spondylitis.
McConkey B
Br J Rheumatol; 1990 Feb; 29(1):2-3. PubMed ID: 1968352
[No Abstract] [Full Text] [Related]
25. Sulphasalazine therapy in chronic uveitis of children with chronic arthritis.
Huang JL; Hung IJ; Hsieh KH
Asian Pac J Allergy Immunol; 1997 Jun; 15(2):71-5. PubMed ID: 9346269
[TBL] [Abstract][Full Text] [Related]
26. Treatment of psoriatic arthritis with sulphasalazine: a one year open study.
Farr M; Kitas GD; Waterhouse L; Jubb R; Felix-Davies D; Bacon PA
Clin Rheumatol; 1988 Sep; 7(3):372-7. PubMed ID: 2906579
[TBL] [Abstract][Full Text] [Related]
27. Tinnitus and bilateral sensorineural hearing loss: ankylosing spondylitis or a side-effect of sulphasalazine treatment?
Savastano M; Marioni G; Bernini G; Punzi L
Acta Otolaryngol; 2005 Jun; 125(6):671-3. PubMed ID: 16076720
[TBL] [Abstract][Full Text] [Related]
28. Toxicity of sulphasalazine in rheumatoid arthritis. Possible protective effect of rheumatoid factors and corticosteroids.
Gran JT; Myklebust G
Scand J Rheumatol; 1993; 22(5):229-32. PubMed ID: 7901898
[TBL] [Abstract][Full Text] [Related]
29. Late onset hypersensitivity to sulfasalazine in a patient with ankylosing spondylitis: comment on the article by Paul et al.
Marino C; McDonald E
Arthritis Care Res; 2000 Oct; 13(5):335; author reply 335. PubMed ID: 14635305
[No Abstract] [Full Text] [Related]
30. [Treatment of juvenile spondylarthritis and reactive arthritis with sulfasalazine].
Suschke HJ
Monatsschr Kinderheilkd; 1992 Sep; 140(9):658-60. PubMed ID: 1359405
[TBL] [Abstract][Full Text] [Related]
31. Sulphasalazine therapy in ankylosing spondylitis: its effect on disease activity, immunoglobulin A and the complex immunoglobulin A-alpha-1-antitrypsin.
Davis MJ; Dawes PT; Beswick E; Lewin IV; Stanworth DR
Br J Rheumatol; 1989 Oct; 28(5):410-3. PubMed ID: 2571386
[TBL] [Abstract][Full Text] [Related]
32. The course of established ankylosing spondylitis and the effects of sulphasalazine over 3 years.
Kirwan J; Edwards A; Huitfeldt B; Thompson P; Currey H
Br J Rheumatol; 1993 Aug; 32(8):729-33. PubMed ID: 8102305
[TBL] [Abstract][Full Text] [Related]
33. Circulating inhibitor bound elastase in patients with ankylosing spondylitis and rheumatoid arthritis and the influence of sulphasalazine treatment.
Feltelius N; Hällgren R
Ann Rheum Dis; 1988 Jan; 47(1):10-4. PubMed ID: 2894204
[TBL] [Abstract][Full Text] [Related]
34. Hypersensitivity reaction to sulfasalazine: skin rash, fever, hepatitis and activated lymphocytes.
Leroux JL; Ghezail M; Chertok P; Blotman F
Clin Exp Rheumatol; 1992; 10(4):427. PubMed ID: 1356682
[No Abstract] [Full Text] [Related]
35. Leucopenia in adult Still's disease during treatment with azathioprine and sulphasalazine.
Bliddal H; Helin P
Clin Rheumatol; 1987 Jun; 6(2):244-50. PubMed ID: 2887331
[TBL] [Abstract][Full Text] [Related]
36. [Sulfasalazine in rheumatology].
Nurchis P; Garau P; Pala MR; Uras L; Saviano M; Mathieu A
Ann Ital Med Int; 1990; 5(3 Pt 1):186-91. PubMed ID: 1981136
[TBL] [Abstract][Full Text] [Related]
37. Sulphasalazine desensitisation in rheumatoid arthritis.
Farr M; Scott DL; Bacon PA
Br Med J (Clin Res Ed); 1982 Jan; 284(6309):118. PubMed ID: 6119134
[No Abstract] [Full Text] [Related]
38. [Experience in the use of salazopyrine EN in patients with spondylarthritis ankylopoietica and rheumatoid arthritis].
Somhegyi A; Gömör B
Orv Hetil; 1988 Sep; 129(36):1917-21. PubMed ID: 2902550
[No Abstract] [Full Text] [Related]
39. Desensitization to sulfasalazine after hypersensitivity reactions in patients with inflammatory bowel disease.
Korelitz BI; Present DH; Rubin PH; Fochios SE
J Clin Gastroenterol; 1984 Feb; 6(1):27-31. PubMed ID: 6142067
[TBL] [Abstract][Full Text] [Related]
40. Clinical efficacy and safety of etanercept versus sulfasalazine in patients with ankylosing spondylitis: a randomized, double-blind trial.
Braun J; van der Horst-Bruinsma IE; Huang F; Burgos-Vargas R; Vlahos B; Koenig AS; Freundlich B
Arthritis Rheum; 2011 Jun; 63(6):1543-51. PubMed ID: 21630245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
